BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
CDMOs and CROs at BIO‑Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
42 CDMOs and CROs are at BIO-Europe 2026 — 35 presentations on the program and 1 with a booth in the exhibit hall. Most represented: Evotec (2 on the program), Lonza (2 on the program), Parexel (2 on the program). 38 of them have their own page in this guide. As of Nov 10, 2026.
Track
Top represented
Showing 1–18 of 42 organizations
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Evotec Hamburg, Germany | ◆Platinum Sponsor |
Drug discovery and development partner providing research services and biologics development and manufacturing to pharma and biotech. | Panel Tue Nov 10 17:00–17:45 Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world. Business of BiotechBiomanufacturing Strategy Panel Wed Nov 11 11:00–12:00 Collaborative Innovation in CDMO Partnerships How drug companies and contract manufacturers develop new therapies together, with examples of what makes these partnerships work and where they struggle. |
Lonza Basel, Switzerland | ◆Platinum Sponsor |
Contract development and manufacturing organization for biologics, small molecules, and cell and gene therapies. | Talk Mon Nov 9 15:30–15:55 Beyond the Race to IND: Balancing Speed, Risk and Future Value When racing to first human trials pays off for a biotech, and when that speed creates risks for manufacturing and growth later on. Panel Tue Nov 10 15:00–15:25 Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience How political uncertainty and trade shifts are changing how drug companies pick outside manufacturers, including whether to produce closer to home. |
Parexel Durham, NC | ◆Platinum Sponsor |
Clinical research organization providing clinical development, regulatory consulting and market access services to biopharmaceutical companies. | Panel Tue Nov 10 14:00–14:25 Navigating the Evolving Regulatory Landscape: Strategies for Clinical Success in an Era of Transformation How rare disease drugs can win approval with few patients, how FDA leadership changes shift priorities, and how real-world data can strengthen applications. Panel Tue Nov 10 16:00–16:45 Unlocking Clinical Trial Systems How EU clinical trial rules and a planned EU biotech law affect trial approval times, and whether Europe can speed up safely. |
FC FGK Clinical Research Munich, Germany | |
German contract research organization running clinical trials for pharma, biotech and medical device companies. | Panel Mon Nov 9 14:30–14:55 Cracking the Translation Gap: Lessons from Germany’s Coordinated Translational Research Model How Germany's coordinated network of health research centres can help turn lab discoveries into therapies and startups, and what stands in the way. Panel Tue Nov 10 09:30–09:55 Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off Five teams from Germany's biotech scene, which spans university research, companies, drug manufacturing and healthcare, show their work and its impact. |
Scientia Clinical Research Sydney, Australia | |
Not-for-profit first-in-human Phase 1 clinical trial unit in the Randwick health precinct, also running later-phase oncology and haematology trials. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
BeNatureBioLab Chuncheon, South Korea | |
Provides formulation development and contract manufacturing for functional foods, cosmetics and pharmaceuticals using hot-melt extrusion drug delivery technology. | Panel Tue Nov 10 14:00–14:30 Korea's Next Wave: Biotech Innovators to Watch Korean biotechs present work spanning drug formulation, safety testing, the microbiome, mRNA and gene therapy delivery, and engineered toxins for cosmetic use. Talk Wed Nov 11 09:50–10:00 Drug Delivery: BeNatureBioLab A Korean university spin-off's solvent-free hot-melt extrusion process that helps poorly soluble drugs dissolve and get absorbed when taken by mouth. |
◆Gold Sponsor | |
Biologics contract development and manufacturing organization formed from Polpharma Biologics, with GMP facilities in Gdansk and near Warsaw. | Talk Tue Nov 10 13:00–14:00 Biologics Manufacturing Excellence How makers of biologics, drugs made in living cells, can expand capacity, clear production bottlenecks and use new technology to work more efficiently. |
Syneos Health Morrisville, NC | ◆Platinum Sponsor |
Contract research and commercialization organization supporting biopharmaceutical companies from clinical development to launch. | Panel Mon Nov 9 13:00–14:00 Navigating partnering and business development in a shifting global landscape How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples. |
WuXi AppTec Shanghai, China | ◆Platinum Sponsor |
Contract research, development and manufacturing organization serving pharma and biotech across small molecules, oligonucleotides, peptides and other modalities. | Panel Tue Nov 10 17:00–17:45 Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world. Business of BiotechBiomanufacturing Strategy |
AB Agilex Biolabs Adelaide, Australia | |
Australian bioanalytical laboratory providing regulated bioanalysis, toxicology and immunology testing for clinical trials. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
Alithia Life Sciences Melbourne, Australia | |
Australian clinical research consultancy supporting Phase I to III trials with project and site management, monitoring and data management. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
Avion CRO Melbourne, Australia | |
Australian contract research organization specializing in imaging for clinical trials, including central reads, dosimetry and radiopharmaceutical studies. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
B BioCina Adelaide, Australia | |
Australian CDMO manufacturing microbial biologics, plasmid DNA and mRNA for clinical and commercial supply. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
Cancer Trials Australia Melbourne, Australia | |
Not-for-profit network of Australian and New Zealand hospital sites and research institutes providing oncology clinical trial management services. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
Cellistic Mont-Saint-Guibert, Belgium | |
Contract development and manufacturing organization for cell therapies derived from induced pluripotent stem cells (iPSCs). | Talk Wed Nov 11 10:30–11:00 From Innovation to Scalable Manufacturing: Closing the Gap Biotechs, researchers and contract manufacturers discuss what it takes to scale a new therapy into a product made reliably under strict quality rules. |
Clinmark Warsaw, Poland | |
Contract research and consulting organization running phase I–IV clinical trials in Central and Eastern Europe and advising on trials worldwide. | Talk Tue Nov 10 14:45–15:00 Technologies and Tools: Clinmark A contract research company running clinical trials for drug and device makers since 2001, with deep experience in Central and Eastern Europe. |
CMAX Clinical Research Adelaide, Australia | |
Australian early-phase clinical trial unit running first-in-human and other early-phase studies for sponsors. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
CMIC Group Tokyo, Japan | |
Japanese contract research and manufacturing group serving drug companies, including clinical trials across Asia. | Panel Tue Nov 10 13:00–13:55 Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region How to run clinical trials and win approval in Japan, Korea, Taiwan and Southeast Asia, and when studies in local patients pay off. |
Find buyers from CDMOs and CROs
Tell us what you sell and we’ll find the people at these CDMOs and CROs most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse BIO-Europe 2026 by
Organization type
Track
Everyone
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction